Abstract:HepatoBiliary Surg Nutr 2020 | http://dx.doi.org/10.21037/hbsn.2020.03.01 A 67-year-old man was admitted to our hospital for a space-occupying lesion in his liver found 1 week earlier. There were no obvious complaints in this patient and no obvious abnormalities were founded during the physical examination. He presented with a habit of heavy drinking (500 mL/day) for more than 40 years. There was no history of other neoplasms, no other history of past illness or any family illness in this patient. The tests for liver function were normal. His serum AFP was 1.7 ng/mL (normal, <20 ng/mL). The levels of other tumor markers, including carcinoembryonic antigen (CEA), carbohydrate antigen 125 (CA125), CA199, and prostatespecific antigen (PSA), were within normal limits. He was positive for serum hepatitis B virus (HBV) surface antigen. Repeat testing for HBV DNA was below the detection value. Abdominal US indicated a well-defined, hypoechoic mass (9.4×8.6 cm) found in the liver, with multiple well-defined mixed heterogenic echoic structures (Figure 1A). Abdominal enhanced CT and MRI revealed a spaceoccupying lesion in liver segments V and VI, which showed obvious enhancement during the arterial phase and relatively receded during the portal and delayed phases compared to the surrounding liver parenchyma, with multiple lesions presenting similar enhancement patterns to that of the lesion (Figure 1B,C). Magnetic resonance diffusion-weighted imaging (DWI) revealed high signal intensity with a nonuniform internal signal (Figure 1D). The patient was diagnosed with HCC with multiple intra-hepatic metastases. Considering the multiple lesions in the liver, it is difficult to obtain biopsies. Finally, to verify the diagnosis, we performed an exploratory laparotomy and a subsequent complete resection of liver segments V and VI (Figure 1E,F). Histopathologically, this liver lesion revealed HCC. Immunohistochemical examination revealed CD34, GPC-3, CD7, HEP positivity, and AFP, CK19 negativity. Meanwhile, histopathological examination of multiple small lesions in the liver revealed biliary hamartomas (BHs) (Figure 1G,H). Based on the results of the histopathological examination, the final diagnosis was modified to synchronous occurrence of HCC and multiple BHs. The patient’s recovery after the operation was uneventful and he was discharged on the ninth postoperative day. On review after 3 months, MRI re-examination showed that the sporadic lesions had not significantly changed, consistent with our diagnosis (Figure 1I).

Clinicopathologic features of dual-phenotype hepatocellular carcinoma

Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma

Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior

Characterization of Genomic Alterations, Tumor Mutational Burden and PDL1 Expression in 181 Chinese Hepatocellular Carcinomas.

Dual-phenotype hepatocellular carcinoma: correlation of MRI features with other primary hepatocellular carcinoma and differential diagnosis

Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma Prognosis

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma

Characteristics, diagnosis, treatment and prognosis of double primary hepatic cancer: experience based on a series of 12 cases

Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma

Diagnostic Value of MRI Features in Dual-phenotype Hepatocellular Carcinoma: A Preliminary Study

Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis

Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma

Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma

Clinicopathologic features of combined hepatic carcinoma

Caractérisation Moléculaire Des Carcinomes Hépatocellulaires Liés Au Virus De L'hépatite B

Clinical Pathological Features and Literature Review of Both HBV and Schistosome Infection Accompanied with Pleomorphic Hepatocellular Carcinoma

Synchronous Occurrence of Hepatocellular Carcinoma and Multiple Biliary Hamartomas Mimicking Hepatocellular Carcinoma with Multiple Intra-Hepatic Metastases.

Hepatitis D virus dual-infection among Chinese hepatitis B patient related to hepatitis B surface antigen, hepatitis B virus DNA and age

Clinicopathological and Contrast Enhanced CT Characters in 19 Cases of Combined Hepatocellular-cholangiocarcinoma